This brand name is authorized in Nigeria
The drug ABONIKI contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE
|
|
Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet. |
|
2
Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
|
|
|
|
3
Camphora
UNII 213N3S8275 - CAMPHOR, (-)-
|
|
|
|
4
Eucalyptus oil
UNII 2R04ONI662 - EUCALYPTUS OIL
|
|
When the vapour is inhaled eucalyptus oil acts to ventilate the bronchial passages and relieve bronchitis and associated conditions. It is also a rubefacient. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M02AC | Preparations with salicylic acid derivatives | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NG | Registered Drug Product Database | Identifier(s): 04-5773 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
